ASTH241220P40000
- 1.50
- 0.000.00%
Astrana Health Newsroom
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
Astrana Health's Strategic Acquisitions and Value-Based Care Drive Bullish Buy Rating
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $86
Astrana Health Analyst Ratings
Lake Street Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $70
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $66
Lake Street Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $70
Stifel Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $70
TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $66
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $67
TD Cowen Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $66
What 5 Analyst Ratings Have To Say About Astrana Health
BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $70
Astrana Health Is Maintained at Buy by BTIG
Astrana Health's Earnings Growth Potential Through RAF Score Enhancement: A Buy Rating Analysis
Analysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX), Astrana Health (ASTH) and Dexcom (DXCM)
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $67